Related Experiment Videos
Oxidative stress and diabetic cardiomyopathy: a brief review
Insights
High blood sugar directly damages heart cells, leading to diabetic cardiomyopathy. This damage, driven by oxidative stress, causes cell death and heart dysfunction, highlighting the need for targeted therapies.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Molecular Biology
Background:
- Diabetes is a major public health issue with heart disease as a leading cause of death in patients.
- Hyperglycemia, or high blood sugar, is an independent risk factor directly causing cardiac damage and diabetic cardiomyopathy.
- Existing research has primarily focused on vascular cells, neglecting the direct impact of hyperglycemia on cardiac myocytes.
Purpose of the Study:
- To review the current understanding of diabetic cardiomyopathy mechanisms.
- To highlight the direct effects of hyperglycemia on cardiac myocytes.
- To emphasize the need for novel prevention and treatment strategies for diabetic cardiac complications.
Main Methods:
- Literature review of current research on diabetic cardiomyopathy.
- Analysis of the role of hyperglycemia as an independent risk factor.
- Examination of molecular mechanisms, including oxidative stress and cell death pathways.
Main Results:
- Hyperglycemia induces oxidative stress through reactive oxygen and nitrogen species production.
- Oxidative stress leads to myocardial injury, abnormal gene expression, and altered signal transduction.
- Programmed myocardial cell death and subsequent cell loss are critical in developing diabetic cardiomyopathy.
Conclusions:
- Diabetic cardiomyopathy results from hyperglycemia-induced oxidative stress and subsequent myocardial cell loss.
- Understanding these mechanisms is crucial for developing targeted therapies.
- Strategies preventing hyperglycemia-induced oxidative myocardial injury show therapeutic promise.
Abstract:
Diabetes is a serious public health problem. Improvements in the treatment of noncardiac complications from diabetes have resulted in heart disease becoming a leading cause of death in diabetic patients. Several cardiovascular pathological consequences of diabetes such as hypertension affect the heart to varying degrees. However, hyperglycemia, as an independent risk factor, directly causes cardiac damage and leads to diabetic cardiomyopathy. Diabetic cardiomyopathy can occur independent of vascular disease, although the mechanisms are largely unknown. Previous studies have paid little attention to the direct effects of hyperglycemia on cardiac myocytes, and most studies, especially in vitro, have mainly focused on the molecular mechanisms underlying pathogenic alterations in vascular smooth-muscle cells and endothelial cells. Thus, a comprehensive understanding of the mechanisms of diabetic cardiomyopathy is urgently needed to develop approaches for the prevention and treatment of diabetic cardiac complications. This review provides a survey of current understanding of diabetic cardiomyopathy. Current consensus is that hyperglycemia results in the production of reactive oxygen and nitrogen species, which leads to oxidative myocardial injury. Alterations in myocardial structure and function occur in the late stage of diabetes. These chronic alterations are believed to result from acute cardiac responses to suddenly increased glucose levels at the early stage of diabetes. Oxidative stress, induced by reactive oxygen and nitrogen species derived from hyperglycemia, causes abnormal gene expression, altered signal transduction, and the activation of pathways leading to programmed myocardial cell deaths. The resulting myocardial cell loss thus plays a critical role in the development of diabetic cardiomyopathy. Advances in the application of various strategies for targeting the prevention of hyperglycemia-induced oxidative myocardial injury may be fruitful.